Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GCK-01
- Development stage
- Unknown
- Lead developer
- Shanghai Jingshan Biotechnology
- Modality
- Cell Therapies
- Administration
- Intravenous
01
Overview
GCK-01 is an allogeneic gamma delta T (γδ T) cell therapy being developed by Shanghai Jingshan Biotechnology for the treatment of hematologic malignancies, specifically relapsed or refractory follicular lymphoma. γδ T cells are a unique subset of T lymphocytes that combine innate and adaptive immune features, capable of recognizing tumor cells in a non-MHC-restricted manner. GCK-01 is designed to be used in combination with monoclonal antibodies like rituximab to enhance anti-tumor activity through antibody-dependent cellular cytotoxicity (ADCC), leveraging the high expression of CD16 on the γδ T cells. The therapy is currently being evaluated in Phase I clinical trials to assess its safety, tolerability, and preliminary efficacy in adult patients.
- Other names
- GCK-01 Cell InjectionGCK01 Cell InjectionGCK 01 Cell Injection
Beyond the preview
Go deeper on GCK-01.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GCK-01.